Jpmorgan Chase & CO Allakos Inc. Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Allakos Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,596 shares of ALLK stock, worth $526. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,596

Previous 1,610 0.87%

Holding current value

$526

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$0.23 - $1.24 $3 - $17	-14 Reduced 0.87%	1,596 $0
Q4 2024 Feb 12, 2025	SELL	$0.62 - $1.5 $4 - $10	-7 Reduced 0.43%	1,610 $1,000
Q3 2024 Dec 26, 2024	SELL	$0.54 - $0.92 $42,967 - $73,204	-79,570 Reduced 98.01%	1,617 $1,000
Q3 2024 Nov 08, 2024	SELL	$0.54 - $0.92 $42,967 - $73,204	-79,570 Reduced 98.01%	1,617 $1,000
Q2 2024 Dec 26, 2024	BUY	$1.0 - $1.45 $79,570 - $115,376	79,570 Added 4920.84%	81,187 $81,000
Q2 2024 Aug 12, 2024	SELL	$1.0 - $1.45 $120,005 - $174,007	-120,005 Reduced 59.65%	81,187 $81,000
Q1 2024 Dec 26, 2024	BUY	$1.02 - $3.23 $203,566 - $644,627	199,575 Added 12342.3%	201,192 $253,000
Q1 2024 May 10, 2024	BUY	$1.02 - $3.23 $156,519 - $495,643	153,450 Added 321.42%	201,192 $253,000
Q4 2023 Dec 26, 2024	BUY	$1.72 - $3.18 $79,335 - $146,677	46,125 Added 2852.5%	47,742 $130,000
Q4 2023 Feb 12, 2024	SELL	$1.72 - $3.18 $21,087 - $38,986	-12,260 Reduced 20.43%	47,742 $130,000
Q3 2023 Nov 14, 2023	BUY	$2.13 - $5.55 $11,176 - $29,120	5,247 Added 9.58%	60,002 $136,000
Q2 2023 Aug 11, 2023	BUY	$3.6 - $5.25 $185,850 - $271,031	51,625 Added 1649.36%	54,755 $238,000
Q1 2023 May 11, 2023	SELL	$4.3 - $8.27 $313,065 - $602,105	-72,806 Reduced 95.88%	3,130 $13,000
Q4 2022 Feb 13, 2023	BUY	$5.66 - $8.42 $335,519 - $499,129	59,279 Added 355.88%	75,936 $639,000
Q3 2022 Nov 14, 2022	SELL	$3.02 - $6.12 $1.81 Million - $3.67 Million	-599,168 Reduced 97.3%	16,657 $102,000
Q2 2022 Aug 11, 2022	BUY	$2.6 - $6.14 $209,188 - $494,005	80,457 Added 15.03%	615,825 $1.93 Million
Q1 2022 May 11, 2022	BUY	$5.08 - $9.81 $2.08 Million - $4.02 Million	409,478 Added 325.27%	535,368 $3.05 Million
Q4 2021 Feb 10, 2022	BUY	$8.55 - $111.89 $855,966 - $11.2 Million	100,113 Added 388.38%	125,890 $1.23 Million
Q3 2021 Nov 12, 2021	BUY	$76.53 - $110.43 $1.97 Million - $2.85 Million	25,777 New	25,777 $2.73 Million

Others Institutions Holding ALLK

# of Institutions

Shares Held

61.7M

Call Options Held

71.5K

Put Options Held

19.8K

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $28M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Allakos Inc. Transaction History